Tag: Apogee Therapeutics

Apogee Therapeutics, Inc. ($APGE) Shares Surge 19% Pre-Market on Breakthrough Phase 2 Trial Results

Apogee Therapeutics, Inc. (APGE) shares surged 19.32% in pre-market trading following strong Phase 2 trial results for APG777, on Monday, July 7, 2025, hitting...

APGE’s APG777 Shows Promise in Treating Moderate-to-Severe Atopic Dermatitis

Apogee Therapeutics, Inc. (APGE) announced positive 16-week data from Part A of the Phase 2 APEX clinical trial of APG777, a potential best-in-class anti-IL-13...